FDA PMA FDA Class 3 Approved 🇺🇸 United States

Implant, Dermal, For Aesthetic Use

PMA: P110033 · Supplement: S044 · Decision Jul 3, 2019
Classifications
1
FEI Numbers
29
Registration Numbers
29

Basic Information

Device Name
Implant, Dermal, For Aesthetic Use
Trade Name
Juvederm Injectable Gel Implants
PMA Number
P110033
Supplement Number
S044
Device Class
FDA Class 3
Product Code
LMH
Generic Name
Implant, dermal, for aesthetic use
Medical Specialty
Unknown
Advisory Committee
General, Plastic Surgery
Decision
Approved
Decision Code
APPR
Decision Date
July 3, 2019
Date Received
April 5, 2019
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for the implementation of the International Council for Harmonisation (ICH) elemental impurities guideline by the raw material supplier for the hyaluronic acid and lidocaine hydrochloride used in the manufacture of the Juvéderm Injectable Gel Implants.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LMH Implant, Dermal, For Aesthetic Use